These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27605222)

  • 1. Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice.
    Zimpfer D; Strueber M; Aigner P; Schmitto JD; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Moscato F; Schima H
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):839-848. PubMed ID: 27605222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term support of patients receiving a left ventricular assist device for advanced heart failure: a follow-up analysis of the Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Schmitto JD; Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):834-838. PubMed ID: 27412342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Timings of the Lavare Cycle on the Ventricular Washout in an In Vitro Flow Visualization Setup.
    Khienwad T; Maurer A; Ghodrati M; Schlöglhofer T; Moscato F; Stoiber M; Schima H; Aigner P
    ASAIO J; 2021 May; 67(5):517-528. PubMed ID: 33606388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the post-market Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE).
    Strueber M; Larbalestier R; Jansz P; Zimpfer D; Fiane AE; Tsui S; Simon A; Schmitto JD; Khaghani A; Wieselthaler GM; Najarian K; Schueler S
    J Heart Lung Transplant; 2014 May; 33(5):486-91. PubMed ID: 24656285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
    Teuteberg JJ; Slaughter MS; Rogers JG; McGee EC; Pagani FD; Gordon R; Rame E; Acker M; Kormos RL; Salerno C; Schleeter TP; Goldstein DJ; Shin J; Starling RC; Wozniak T; Malik AS; Silvestry S; Ewald GA; Jorde UP; Naka Y; Birks E; Najarian KB; Hathaway DR; Aaronson KD;
    JACC Heart Fail; 2015 Oct; 3(10):818-28. PubMed ID: 26450000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device.
    John R; Aaronson KD; Pae WE; Acker MA; Hathaway DR; Najarian KB; Slaughter MS;
    J Heart Lung Transplant; 2014 Oct; 33(10):1066-73. PubMed ID: 25087103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.
    Dell'Aquila AM; Schneider SR; Schlarb D; Redwan B; Sindermann JR; Ellger B; Stypmann J; Tjan TD; Scheld HH; Hoffmeier A
    Ann Thorac Surg; 2013 Jan; 95(1):170-7. PubMed ID: 23141906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M; Schmitto JD
    Circ Heart Fail; 2020 Mar; 13(3):e006252. PubMed ID: 32164438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.
    Shehab S; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Robson D; Newton PJ; Rao S; Wang L; Allida S; Connellan M; Granger E; Dhital K; Spratt P; Jansz PC; Hayward CS
    J Heart Lung Transplant; 2016 Apr; 35(4):466-73. PubMed ID: 26849954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biventricular circulatory support with two miniaturized implantable assist devices.
    Krabatsch T; Potapov E; Stepanenko A; Schweiger M; Kukucka M; Huebler M; Hennig E; Hetzer R
    Circulation; 2011 Sep; 124(11 Suppl):S179-86. PubMed ID: 21911810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design changes in continuous-flow left ventricular assist devices and life-threatening pump malfunctions.
    Soltani S; Kaufmann F; Vierecke J; Kretzschmar A; Hennig E; Stein J; Hetzer R; Krabatsch T; Potapov EV
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):984-9. PubMed ID: 25209626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombus on the inflow cannula of the HeartWare HVAD: an update.
    Glass CH; Christakis A; Fishbein GA; Watkins JC; Strickland KC; Mitchell RN; Padera RF
    Cardiovasc Pathol; 2019; 38():14-20. PubMed ID: 30399526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lavare Cycle: A Novel Pulsatile Feature of the HVAD Continuous-Flow Left Ventricular Assist Device.
    Kumar J; Elhassan A; Dimitrova G; Essandoh M
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1170-1171. PubMed ID: 30630656
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of paracorporeal and continuous flow ventricular assist devices in children: preliminary results.
    Nassar MS; Hasan A; Chila T; Schueler S; Pergolizzi C; Reinhardt Z; Lord S; De Rita F; Ferguson L; Smith J; Haynes S; O'Sullivan J; Murtuza B
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):709-714. PubMed ID: 28329112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two implantable continuous-flow ventricular assist devices in a biventricular configuration: technique and results.
    Eulert-Grehn JJ; Lanmüller P; Schönrath F; Solowjowa N; Müller M; Mulzer J; Kaufmann F; Starck C; Krabatsch T; Falk V; Potapov E
    Interact Cardiovasc Thorac Surg; 2018 Dec; 27(6):938-942. PubMed ID: 30113626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes.
    Bashir J; Legare JF; Freed DH; Cheung A; Rao V; Toma M
    Can J Cardiol; 2014 Dec; 30(12):1662-7. PubMed ID: 25475468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.